(Q38445611)

3 September 2017

0 references

1 reference

title

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

3 September 2017

0 references

1 reference

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

6

Ara Darzi

1 reference

3 September 2017

Thanos Athanasiou

7

0 references

Leanne Harling

series ordinal

3

object named as

Leanne Harling

1 reference

3 September 2017

8

Hutan Ashrafian

1 reference

3 September 2017

5

Evangelos Efthimiou

1 reference

3 September 2017

2

Tania Toma

1 reference

3 September 2017

Guy Bower

1

1 reference

PubMed ID

25917981

3 September 2017

Long R Jiao

series ordinal

4

1 reference

3 September 2017

29 April 2015

1 reference

3 September 2017

1 reference

3 September 2017

25

1 reference

3 September 2017

12

1 reference

3 September 2017

2280-2289

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-015-1691-x

3 September 2017

0 references

cites work

The burden of liver disease in Europe: a review of available epidemiological data

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Global burden of obesity in 2005 and projections to 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Benefits of lifestyle modification in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

The emperor's tailors: the failure of the medical weight loss paradigm and its causal role in the obesity of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

The incidence of bariatric surgery has plateaued in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Long-term mortality after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Comparison of nutritional status during the first year after sleeve gastrectomy and Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Serum phenylalanine concentration as a marker of liver function in obese patients before and after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Nonalcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non-Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Hepatic outcomes after jejunoileal bypass: is there a publication bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Results of laparoscopic gastric bypass in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Metabolic surgery and cancer: protective effects of bariatric procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Autobionics: a new paradigm in regenerative medicine and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Human gut microbiota in obesity and after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Effects of bariatric surgery on cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Association of Adipose Tissue and Liver Fibrosis With Tissue Stiffness in Morbid Obesity: Links With Diabetes and BMI Loss After Gastric Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1691-X

Histological findings in the liver before and after gastric bypass

21 January 2018

1 reference

12 December 2020

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

1 reference

12 December 2020

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

12 December 2020

Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience

1 reference

12 December 2020

Effect of bariatric surgery on liver fibrosis

1 reference

12 December 2020

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years

1 reference

12 December 2020

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome

1 reference

12 December 2020

Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity

1 reference

12 December 2020

Nonalcoholic fatty liver disease treated by gastroplasty

1 reference

12 December 2020

Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients

1 reference

12 December 2020

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

12 December 2020

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

12 December 2020

Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study

1 reference

12 December 2020

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

1 reference

12 December 2020

Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children.

1 reference

12 December 2020

Is bariatric surgery safe in cirrhotics?

1 reference

12 December 2020

Non-alcoholic fatty liver disease

1 reference

12 December 2020

The evolution of severe steatosis after bariatric surgery is related to insulin resistance

1 reference

12 December 2020

10.1007/S11695-015-1691-X

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

25917981